Tissue Regeneration Therapeutics Inc. Receives Defense Acquisition Challenge Grant

WOODSTOCK, Ga.--(BUSINESS WIRE)--Tissue Regeneration Technologies, LLC (TRT) is proud to announce the receipt of a $2 million grant from the Defense Acquisition Challenge (DAC) for fiscal year 2009. TRT's proposal "Shockwave Therapy for Traumatic Wounds of the Extremity" is designed to evaluate the effectiveness of shockwave therapy in treating complex wounds in a combat casualty care venue. TRT's Department of Defense partner, the Combat Wound Initiative (CWI) Program, is currently spearheading a randomized clinical trial evaluating the efficacy of shock wave therapy.